Lung cancer and leukaemia treatments to be added to PBS

19 November 2019 - “Game changing” drugs for types of lung cancer and leukaemia will be added to the Pharmaceutical Benefits ...

Read more →

Alkermes submits new drug application to U.S. FDA for ALKS 3831 for treatment of schizophrenia and bipolar I disorder

19 November 2019 - Alkermes today announced that it has submitted a new drug application to the U.S. FDA seeking ...

Read more →

Newron receives FDA rare paediatric disease designation for sarizotan for the treatment of Rett syndrome

19 November 2019 - Newron announced today that the U.S. FDA has granted the rare paediatric disease designation for sarizotan, ...

Read more →

Life saving therapy denied to dying cop

20 November 2019 - Doctors at Sydney’s Royal Prince Alfred Hospital are refusing to treat a terminally ill cancer ­patient ...

Read more →

Private health premiums tipped to soar as more young people drop cover

19 November 2019 - Health Minister Greg Hunt's effort to slow the increase in the cost of health insurance has ...

Read more →

Generic drug approvals soar, but patients still go without

19 November 2019 - Brand name makers’ patent action limits release of the lower-price medicines, hindering cost-control efforts. ...

Read more →

Medexus granted priority review status for Gliolan by Health Canada

19 November 2019 - Medexus Pharmaceuticals today announced that Health Canada has granted priority review status for the new drug ...

Read more →

Genmab announces European marketing authorization for Darzalex (daratumumab) in combination with lenalidomide and dexamethasone in frontline multiple myeloma

19 November 2019 - Approval based on data from Phase III MAIA study. ...

Read more →

Orphazyme receives breakthrough therapy designation for arimoclomol in Niemann-Pick disease Type C

19 November 2019 - Orphazyme today announces that the US FDA has granted breakthrough therapy designation for arimoclomol, an investigational drug ...

Read more →

Game changing cancer medicines now within reach for 2,200 Australians

20 November 2019 - Australians living with non-small cell lung cancer and early stage acute lymphoblastic leukaemia will be able to ...

Read more →

Withdrawal from the drug benefits on 1 December

15 November 2019 - Below is a compilation of the medicines in different packaging sizes which, at the companies' own ...

Read more →

FDA accepts Samsung Bioepis’ BLA for SB8 bevacizumab biosimilar candidate

19 November 2019 - Samsung Bioepis today announced that the U.S. FDA has accepted for review the company’s biologics license ...

Read more →

In a rare political move, prominent biotech venture capitalists speak out against Pelosi’s drug pricing bill

18 November 2019 - A group of top biotech venture capitalists are issuing a stark warning to Congress: They won’t ...

Read more →

AMA develops Rx for drug prices that are high and rising

19 November 2019 - Arbitration in determining prescription drug prices is a viable mechanism to address the burden of high and ...

Read more →

Here’s why pharmaceutical companies raise their prices so much

19 November 2019 - Yes, I’ve ranted about healthcare prices before. On more than one occasion.  ...

Read more →